Notable Labs, Ltd.
NTBLNASDAQHealthcare
$0.25
$-0.09(-27.68%)
Market Cap$2394590
P/E Ratio—
52W High$4.24
52W Low$0.22
Notable Labs, Ltd. (NTBL) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
NTBL · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2024Report Date: Nov 12, 2024EPS Actual
-$0.48
Est. -$0.68 · +29.4%
Revenue
—
Fiscal Period
Q4 FY2024
FY ends December
Report Date
Nov 12, 2024
After Market Close
▲ Beat EPS✓ 1-Quarter EPS Beat Streak
NTBL reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$-0.11
Rev. $0.17B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$-0.11
Rev. Est.$0.17B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2025 | Aug 12, 2025 | — | — | — | — | — | — |
| ◌ Q2 FY2025 | May 13, 2025 | — | — | — | — | — | — |
| ▲ Q4 FY2024 | Nov 12, 2024 | -$0.68 | -$0.48 | +29.4% | — | — | — |
| ▼ Q3 FY2024 | Aug 14, 2024 | -$0.43 | -$0.55 | -27.9% | $0.00B | — | — |
| ▼ Q2 FY2024 | May 15, 2024 | -$0.39 | -$0.42 | -7.7% | $0.00B | — | — |
| ▼ Q1 FY2024 | Mar 22, 2024 | -$0.43 | -$5.46 | -1169.8% | — | — | — |
| ▼ Q4 FY2023 | Nov 14, 2023 | -$0.41 | -$0.48 | -17.1% | — | — | — |
| ▲ Q3 FY2023 | Aug 14, 2023 | -$4.90 | -$0.01 | +99.8% | — | $0.00B | — |
Q3 FY2025
Aug 12, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
May 13, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Nov 12, 2024Beat
EPS Actual
-$0.48
EPS Est.
-$0.68
EPS Surpr.
+29.4%
Revenue
—
Q3 FY2024
Aug 14, 2024Miss
EPS Actual
-$0.55
EPS Est.
-$0.43
EPS Surpr.
-27.9%
Revenue
$0.00B
Q2 FY2024
May 15, 2024Miss
EPS Actual
-$0.42
EPS Est.
-$0.39
EPS Surpr.
-7.7%
Revenue
$0.00B
Q1 FY2024
Mar 22, 2024Miss
EPS Actual
-$5.46
EPS Est.
-$0.43
EPS Surpr.
-1169.8%
Revenue
—
Q4 FY2023
Nov 14, 2023Miss
EPS Actual
-$0.48
EPS Est.
-$0.41
EPS Surpr.
-17.1%
Revenue
—
Q3 FY2023
Aug 14, 2023Beat
EPS Actual
-$0.01
EPS Est.
-$4.90
EPS Surpr.
+99.8%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $-1.05 | $-1.05 | $-1.05 | 1 |
| Q3 FY2025 | $-0.97 | $-0.97 | $-0.97 | 1 |
| Q2 FY2025 | $-0.91 | $-0.91 | $-0.91 | 1 |
| Q1 FY2025 | $-0.79 | $-0.79 | $-0.79 | 1 |
| Q4 FY2024 | $-0.73 | $-0.73 | $-0.73 | 1 |
| Q3 FY2024 | $-0.68 | $-0.68 | $-0.68 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q4 FY2024 | Nov 12, 2024 | +29.4% | $0.05 | $0.05 | +0.00% |
| ▼ Q3 FY2024 | Aug 14, 2024 | -27.9% | $0.47 | $0.50 | +5.27% |
| ▼ Q2 FY2024 | May 15, 2024 | -7.7% | $1.10 | $1.08 | -1.82% |
| ▼ Q1 FY2024 | Mar 22, 2024 | -1169.8% | $1.71 | $1.91 | +11.70% |
| ▼ Q4 FY2023 | Nov 14, 2023 | -17.1% | $3.03 | $3.27 | +7.92% |
| ▲ Q3 FY2023 | Aug 14, 2023 | +99.8% | $8.05 | $8.33 | +3.48% |
| ▲ Q2 FY2023 | May 15, 2023 | +99.4% | $7.35 | $7.00 | -4.76% |
| ▲ Q4 FY2022 | Dec 30, 2022 | +66.5% | $4.20 | $4.20 | +0.00% |
Q4 FY2024+0.00%
Report Date
Nov 12, 2024
EPS Beat/Miss
+29.4%
Price Before
$0.05
Price After
$0.05
Q3 FY2024+5.27%
Report Date
Aug 14, 2024
EPS Beat/Miss
-27.9%
Price Before
$0.47
Price After
$0.50
Q2 FY2024-1.82%
Report Date
May 15, 2024
EPS Beat/Miss
-7.7%
Price Before
$1.10
Price After
$1.08
Q1 FY2024+11.70%
Report Date
Mar 22, 2024
EPS Beat/Miss
-1169.8%
Price Before
$1.71
Price After
$1.91
Q4 FY2023+7.92%
Report Date
Nov 14, 2023
EPS Beat/Miss
-17.1%
Price Before
$3.03
Price After
$3.27
Q3 FY2023+3.48%
Report Date
Aug 14, 2023
EPS Beat/Miss
+99.8%
Price Before
$8.05
Price After
$8.33
Q2 FY2023-4.76%
Report Date
May 15, 2023
EPS Beat/Miss
+99.4%
Price Before
$7.35
Price After
$7.00
Q4 FY2022+0.00%
Report Date
Dec 30, 2022
EPS Beat/Miss
+66.5%
Price Before
$4.20
Price After
$4.20
Avg Beat Reaction-0.32%
Avg Miss Reaction+5.77%
Beat Rate4 / 8 quarters
Largest Move+11.70% (Q1 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: NTBL ends December
Notable Labs, Ltd. (NTBL) most recently reported earnings on November 12, 2024 for Q4 FY2024, posting EPS of $-0.48 — beating the analyst consensus of $-0.68 by +29.4%. The next NTBL earnings date is expected around September 1, 2026.
Each quarter, investors track NTBL earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. NTBL revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
NTBL's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
NTBL earnings · 5 questionsNotable Labs, Ltd.'s next earnings report is expected around September 1, 2026. NTBL typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; NTBL historically reports after market close (AMC).
NTBL earnings datewhen is NTBL earningsNTBL next earnings datewhen does NTBL report earningsNTBL earnings calendar
▸ Source: FMP · Notable Labs, Ltd. SEC filings · US GAAP · Notable Labs, Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026